Meeting
2024 ASCO Annual Meeting
Prediction of recurrence in stage I EGFR mutation-positive NSCLC: Combination of CT appearance and selected co-occurring gene alterations by machine learning.
Authors
Akiko Tateishi
Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan
Akiko Tateishi , Hidehito Horinouchi , Ken Takasawa , Nobuji Kouno , Takaaki Mizuno , Yu Okubo , Yukihiro Yoshida , Shun-ichi Watanabe , Mototaka Miyake , Masahiko Kusumoto , Koji Inaba , Hiroshi Igaki , Yasushi Yatabe , Masami Mukai , Katsuya Tanaka , Naoki Mihara , Kouya Shiraishi , Takashi Kohno , Yuichiro Ohe , Ryuji Hamamoto
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Local-Regional Non–Small Cell Lung Cancer
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 8053)
DOI
10.1200/JCO.2024.42.16_suppl.8053
Abstract #
8053
Poster Bd #
315
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Postoperative ctDNA in indicating the recurrence risk and monitoring the effect of adjuvant therapy in surgical non–small cell lung cancers.
First Author: Xiaoru Tian
Poster
2023 ASCO Annual Meeting
Development and validation of a prediction model for the recurrence of stage 1 EGFR mutation positive NSCLC in patients using machine learning with WES-based gene sets.
First Author: Akiko Tateishi
Poster
2023 ASCO Annual Meeting
Elucidating the genomic and transcriptomic landscape of L858R vs ex19del EGFR-mutated NSCLC.
First Author: Stephanie Pei Li Saw
Poster
2023 ASCO Annual Meeting
Clinical and financial implications of ADUARA trial on a real-world population.
First Author: Bharathi Muthusamy